Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 4,920.00
0.00 (0.00%)
At close: Feb 13, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 33.56 billion as of February 13, 2026. Its market cap has decreased by -53.68% in one year.
Market Cap
33.56B
Enterprise Value
36.27B
Revenue
345.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
4,920.00
Market Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 33.56B, a decrease of -71.69%. That is a compound annual growth rate of -23.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 33.56B | 20.00% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | 118.51B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| QuantaMatrix | 81.69B |
| JPI Healthcare | 79.39B |
| Hironic | 74.74B |
| DRGEM | 59.49B |
| Neofect | 58.49B |
| Genoray | 54.06B |
| UXN Co., Ltd. | 41.64B |
| CU Medical Systems | 35.53B |